Provider Profile:
David Gorski, M.D., Ph.D.

• Breast Cancer

School

• University of Michigan Medical School

Residency

• General Surgery, University Hospitals of Cleveland Case Western Reserve University School of Medicine, Cleveland, OH

Fellowships

• Research Fellow, Section of Surgical Oncology, University of Chicago, Chicago, IL

Awards

• Conquer Cancer Foundation of ASCO and Breast Cancer Research Foundation
• Clinical Research Award in Breast Cancer, 2007 Managing Editor of the Science-Based Medicine weblog

Professional Memberships

• Co-director, Michigan Breast Oncology Quality Initiative (MiBOQI)
• American College of of Surgeons Committee on Cancer (ACS CoC) Cancer Liason Physician
• American Association of Breast Surgeons
• American Society of Clinical Oncology
• Society of Surgical Oncology

• Speyer, C. L., M. A. Nasar, A. H. Hachem, M. A. Bukhsh, W. S. Jafry, R. Khansa, and D. H. Gorski (2016). Riluzole mediates anti-tumor properties in breast cancer cells independent of metabotropic glutamate receptor-1 (mGluR1). Breast Cancer Res. Treat. 157:217-228. 

  Henry, N.L., T. Braun, H.Y. Ali, K. Munir, S. M. Silver, D. H. Gorski, T.M. Breslin, J. J. Griggs (2017). Associations between use of the 21-gene recurrence score assay and chemotherapy regimen selection in a statewide registry. Cancer 123:948-956.

  Speyer, C. L., A. Hachem, and D. H. Gorski (2017). Riluzole synergizes with paclitaxel to inhibit cell growth and induce apoptosis in triple-negative breast cancer. Breast Cancer Res Treat 166:407-419.

  Holowatyj, A. N., M. L. Cote, J. J. Ruterbusch, K. Ghanem, A. G. Schwartz, F. D. Vigneau, V. Petkov, D. H. Gorski, K. S. Purrington (2018). Racial Differences in 21-gene Recurrence Scores among Patients with Hormone Receptor-Positive, Node-Negative Breast Cancer. J Clin Oncol. 36(7):652-658.

  Frontera, E.D., R. M. Khansa, D. L. Schalk, L. E. Leakan, T. J. Guerin-Edbauer, M. Ratnam, D. H. Gorski, and C. L. Speyer (2018). IgA Fc-folate conjugate activates and recruits neutrophils to directly target triple-negative breast cancer cells. Breast Cancer Res Treat 172: 551-560.

  Sexton R. E., A. H. Hachem, A. A. Assi, M. A. Bukhsh, D. H. Gorski, and C. L. Speyer (2018). Metabotropic glutamate receptor-1 regulates inflammation in triple negative breast cancer. Sci Rep 8: 16008.

  Holowatyj, A. N., E. I. Heath, L. M. Pappas, J. J. Ruterbusch, D. H. Gorski, J. A. Triest, H. K. Park, J. L. Beebe-Dimmer, A. G. Schwartz, M. L. Cote, and K. L. Schwartz (2019). The Epidemiology of Cancer Among Homeless Adults in Metropolitan Detroit. JNCI Cancer Spectr 3(1):pkz006.